Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.11 - $2.34 $49,506 - $104,364
44,600 New
44,600 $103,000
Q1 2023

May 15, 2023

BUY
$4.0 - $7.02 $36,172 - $63,481
9,043 Added 56.65%
25,006 $102,000
Q4 2022

Feb 14, 2023

BUY
$5.65 - $7.86 $90,190 - $125,469
15,963 New
15,963 $93,000
Q2 2022

Aug 15, 2022

SELL
$2.84 - $5.0 $161,880 - $285,000
-57,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.74 - $6.63 $213,180 - $377,910
57,000 New
57,000 $227,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $52.5M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.